Biocept Names Antonino Morales As President and CEO; Succeeds Interim President and CEO Samuel Riccitelli Effective Immediately
Portfolio Pulse from Benzinga Newsdesk
Biocept has appointed Antonino Morales as its new President and CEO, effective immediately. He succeeds interim President and CEO Samuel Riccitelli.

June 20, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biocept has named Antonino Morales as its new President and CEO, succeeding interim CEO Samuel Riccitelli.
The appointment of a new CEO typically has a neutral short-term impact on a company's stock price. While Antonino Morales may bring new strategies and direction to Biocept, it is too early to determine the exact impact on the company's performance and stock price. The market will likely wait to see how Morales' leadership affects Biocept before reacting significantly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100